We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
신규 편입 · 포트폴리오 비중 0.00%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $23.17 · 6 analysts
Stored first · Google News · Yahoo Finance (English)
Pediatrix Medical Group (MD) Reaffirms Outlook Following Stable Payor Mix, Is The Strength Already Priced In? - simplywall.st
Pediatrix Medical Group (MD) Reaffirms Outlook Following Stable Payor Mix, Is The Strength Already Priced In? simplywall.st
A Look at Pediatrix Medical Group Inc (MD) After 7.3% Gain -- GF Value $13.18 vs Price $25.88 - GuruFocus
A Look at Pediatrix Medical Group Inc (MD) After 7.3% Gain -- GF Value $13.18 vs Price $25.88 GuruFocus
ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues
Pediatrix Medical (MD) Maintains Stable Q2 Trends Amid Market Sh - GuruFocus
Pediatrix Medical (MD) Maintains Stable Q2 Trends Amid Market Sh GuruFocus
Pediatrix Medical Group Reiterates 2026 Adjusted EBITDA Outlook
Pediatrix Medical Group Provides Second Quarter Update
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 04. | After market close (AMC) | $0.59 | — | — | $478M | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 13. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 04. 14. | Truist Securities | — | Maintain | Hold → Hold | — | Truist Securities: Hold |
| 2026. 02. 25. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 02. 21. | Truist Securities | — | Maintain | Hold → Hold | — | Truist Securities: Hold |
| 2025. 11. 11. | Truist Securities | — | Maintain | Hold → Hold | — | Truist Securities: Hold |
| 2025. 11. 06. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 48,372 | $1.03M | 0.00% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 39,672 | $848.58K | 0.00% | — | New position |